Evoke Pharma Inc Annual Return On Assets in % from 2014 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Evoke Pharma Inc quarterly/annual Return On Assets history and growth rate from 2014 to 2024.
  • Evoke Pharma Inc Return On Assets for the quarter ending December 31, 2024 was -38.1 %, a 58.6% increase year-over-year.
  • Evoke Pharma Inc annual Return On Assets for 2024 was -38.1 %, a 58.6% increase from 2023.
  • Evoke Pharma Inc annual Return On Assets for 2023 was -91.8 %, a 109% decline from 2022.
  • Evoke Pharma Inc annual Return On Assets for 2022 was -44 %, a 23.9% increase from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -38.1 +53.8 +58.6% Jan 1, 2024 Dec 31, 2024
2023 -91.8 -47.9 -109% Jan 1, 2023 Dec 31, 2023
2022 -44 +13.8 +23.9% Jan 1, 2022 Dec 31, 2022
2021 -57.8 +123 +68% Jan 1, 2021 Dec 31, 2021
2020 -181 -70.1 -63.2% Jan 1, 2020 Dec 31, 2020
2019 -111 +10.8 +8.85% Jan 1, 2019 Dec 31, 2019
2018 -122 -16.8 -16.1% Jan 1, 2018 Dec 31, 2018
2017 -105 +31.2 +23% Jan 1, 2017 Dec 31, 2017
2016 -136 -26.9 -24.6% Jan 1, 2016 Dec 31, 2016
2015 -109 -31.4 -40.4% Jan 1, 2015 Dec 31, 2015
2014 -77.7 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.